SCHEMBL7985863

SCHEMBL7985863

CCCc1nc(=O)c2c(ncn2Cc2cccnc2)[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 3/20 0.57
KDM4E B2RXH2 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
POLB P06746 1/20 0.41
PARN O95453 1/20 0.41
PKM P14618 2/20 0.39
TLR7 Q9NYK1 1/20 0.39
KDM4C Q9H3R0 2/20 0.39
UBE2N P61088 1/20 0.38
ATM Q13315 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRA5 P31644 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ALOX5 P09917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989411 0.88 CNOT7 (0.53) CNOT7HPGDSMN1; SMN2POLBPARN
SCHEMBL7974259 0.86 CNOT7 (0.54) CNOT7KDM4EL3MBTL1HPGDHSD17B10
SCHEMBL7985687 0.83 CNOT7 (0.55) CNOT7KDM4EL3MBTL1HPGDSMN1; SMN2
SCHEMBL7985859 0.83 CNOT7 (0.49) CNOT7KDM4EL3MBTL1HPGDSMN1; SMN2
SCHEMBL7988665 0.83 ALDH1A1 (0.44) CNOT7HPGDSMN1; SMN2LMNAHTT
SCHEMBL7989379 0.82 CNOT7 (0.41) CNOT7KDM4EHPGDSMN1; SMN2LMNA
SCHEMBL7988487 0.82 PDE1A (0.46) CNOT7KDM4EHPGDLMNAPARN
SCHEMBL7991727 0.82 SMN1; SMN2 (0.49) CNOT7L3MBTL1SMN1; SMN2HTTPARN
SCHEMBL7988961 0.81 KDM4E (0.42) CNOT7KDM4EHPGDSMN1; SMN2LMNA
SCHEMBL7987612 0.81 CNOT7 (0.51) CNOT7HPGDSMN1; SMN2POLBPARN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed